Literature DB >> 1933667

Schnyder's crystalline corneal dystrophy in association with hyperlipoproteinemia: histopathological and ultrastructural findings.

S Brownstein1, W B Jackson, R M Onerheim.   

Abstract

A 61-year-old man with Schnyder's crystalline corneal dystrophy showed a slight reduction in vision during 16 years of observation. Plasma lipoprotein analysis done 10 years after presentation showed type IIA hyperlipoproteinemia, which was also detected in one of four siblings examined, none of whom showed the characteristic corneal dystrophy. Electron microscopic studies on corneal biopsy specimens from the patient showed abundant crystalline material and vacuoles predominantly in the superficial corneal stroma, with occasional keratocytes and rare basal epithelial cells containing laminated structures. The findings of a focal continuity between the trilaminar membrane around some of the stromal vacuoles and the plasmalemma of the keratocytes as well as dissolution of the plasmalemma in other keratocytes are consistent with the hypothesis of a local cellular role in the development of this corneal disorder.

Entities:  

Mesh:

Year:  1991        PMID: 1933667

Source DB:  PubMed          Journal:  Can J Ophthalmol        ISSN: 0008-4182            Impact factor:   1.882


  9 in total

1.  Geranylgeranyl-regulated transport of the prenyltransferase UBIAD1 between membranes of the ER and Golgi.

Authors:  Marc M Schumacher; Dong-Jae Jun; Youngah Jo; Joachim Seemann; Russell A DeBose-Boyd
Journal:  J Lipid Res       Date:  2016-04-27       Impact factor: 5.922

2.  Visual morbidity in thirty-four families with Schnyder crystalline corneal dystrophy (an American Ophthalmological Society thesis).

Authors:  Jayne S Weiss
Journal:  Trans Am Ophthalmol Soc       Date:  2007

3.  A mutation in the UBIAD1 gene in a Han Chinese family with Schnyder corneal dystrophy.

Authors:  Chunyu Du; Ying Li; Lili Dai; Lingmin Gong; Chengcheng Han
Journal:  Mol Vis       Date:  2011-10-15       Impact factor: 2.367

4.  The prenyltransferase UBIAD1 is the target of geranylgeraniol in degradation of HMG CoA reductase.

Authors:  Marc M Schumacher; Rania Elsabrouty; Joachim Seemann; Youngah Jo; Russell A DeBose-Boyd
Journal:  Elife       Date:  2015-03-05       Impact factor: 8.140

5.  Schnyder corneal dystrophy-associated UBIAD1 inhibits ER-associated degradation of HMG CoA reductase in mice.

Authors:  Youngah Jo; Jason S Hamilton; Seonghwan Hwang; Kristina Garland; Gennipher A Smith; Shan Su; Iris Fuentes; Sudha Neelam; Bonne M Thompson; Jeffrey G McDonald; Russell A DeBose-Boyd
Journal:  Elife       Date:  2019-02-20       Impact factor: 8.140

6.  Crystalline-like keratopathy after intravenous immunoglobulin therapy with incomplete kawasaki disease: case report and literature review.

Authors:  Elif Erdem; Emine Kocabas; Hande Taylan Sekeroglu; Ozlem Ozgür; Meltem Yagmur; T Reha Ersoz
Journal:  Case Rep Ophthalmol Med       Date:  2013-03-28

7.  Mutations in the UBIAD1 gene, encoding a potential prenyltransferase, are causal for Schnyder crystalline corneal dystrophy.

Authors:  Andrew Orr; Marie-Pierre Dubé; Julien Marcadier; Haiyan Jiang; Antonio Federico; Stanley George; Christopher Seamone; David Andrews; Paul Dubord; Simon Holland; Sylvie Provost; Vanessa Mongrain; Susan Evans; Brent Higgins; Sharen Bowman; Duane Guernsey; Mark Samuels
Journal:  PLoS One       Date:  2007-08-01       Impact factor: 3.240

8.  Analysis of conjunctival fibroblasts from a proband with Schnyder corneal dystrophy.

Authors:  Jodhbir S Mehta; Eranga N Vithana; Divya Venkataraman; Anandalakshmi Venkatraman; Rebekah Poh; Roger W Beuerman; Tin Aung; Donald T H Tan
Journal:  Mol Vis       Date:  2008-07-09       Impact factor: 2.367

9.  Functional study of SCCD pathogenic gene UBIAD1 (Review).

Authors:  Jumin Xie; Lingxing Li
Journal:  Mol Med Rep       Date:  2021-08-09       Impact factor: 2.952

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.